Ursodeoxycholic Acid

Your liver pours bile into your intestine every time you eat fat. Most of that bile gets reabsorbed and recycled, but the small fraction that makes it to your stool carries a chemical fingerprint of what your gut bacteria are doing. Measuring ursodeoxycholic acid (UDCA) in stool is one window into that fingerprint.

UDCA is a so-called secondary bile acid, made when gut microbes modify the bile acids your liver originally produced. Its level in stool tells you something about both your bile acid handling and the microbial communities doing the work. This is a research-stage measurement without universally agreed cutpoints, so the value lies in tracking your own pattern over time and reading it alongside other markers of gut and liver health.

Why Bile Acids in Stool Matter

Bile acids are not just digestive detergents. They shape which bacteria thrive in your colon, influence inflammation in your gut wall, and act as signaling molecules that affect metabolism throughout the body. The mix of bile acids reaching your stool is the end result of a long chain of events: liver production, gallbladder release, intestinal absorption, and microbial transformation.

Two patterns matter most. The total amount of bile acid in stool tells you how much is escaping reabsorption. The relative balance between different bile acids, including UDCA, tells you what your microbes are doing with the bile acid pool they receive. UDCA sits in a small but interesting corner of this profile. It is generally considered a gentler, more water-friendly bile acid compared with harsher ones like deoxycholic acid, though the picture is more nuanced for lithocholic acid, which can be cell-damaging to the liver but also has anti-inflammatory effects in the colon.

Colorectal Cancer Associations

A systematic review and meta-analysis of fecal bile acid studies found that people in higher-risk groups for colorectal cancer had higher fecal UDCA than people in lower-risk groups, with a standardized mean difference of 0.46 (95% CI 0.14 to 0.78). The same analysis found that the overall fecal bile acid load was elevated in higher-risk groups (SMD 0.36, 95% CI 0.21 to 0.51). These were cross-sectional and case-control studies, not prospective cohorts, so the direction of cause and effect is not settled.

This finding can feel confusing, because oral UDCA has been studied as a possible cancer protector. In a meta-analysis of people with primary sclerosing cholangitis and inflammatory bowel disease (763 patients, 177 cases of colorectal neoplasia), the overall pooled estimate for any UDCA use and any colorectal neoplasia was not statistically significant (OR 0.81, 95% CI 0.41 to 1.61). Within that meta-analysis, low-dose oral UDCA at 8 to 15 mg per kg per day was associated with about 80% lower odds of any colorectal neoplasia (OR 0.19, 95% CI 0.08 to 0.49), and overall UDCA use was associated with reduced risk of advanced neoplasia (OR 0.35, 95% CI 0.17 to 0.73). A separate meta-analysis (Hansen et al. 2013) also found no significant overall association. So the chemopreventive signal is real for specific subgroups but more modest than headline numbers suggest.

Reconciling the Two Findings

One plausible interpretation of these results is that higher endogenous fecal UDCA in someone not taking the drug may reflect a generally elevated and disturbed bile acid pool, the same kind of disturbance that produces higher levels of the more harmful secondary bile acids. Therapeutic UDCA, taken at gram-level doses, swamps the natural pool with a single gentle bile acid and may shift the overall balance toward a less inflammatory profile. This is a reasonable mechanistic story rather than a fully established one. The number on your lab report is not a verdict on its own. It is one input that has to be read alongside the other bile acids in the same panel, your symptoms, and your broader gut health picture.

Gut Microbiome and Bile Acid Handling

Your fecal bile acid pattern reflects which bacteria are active in your gut. Research in people with primary biliary cholangitis who responded incompletely to oral UDCA found lower fecal secondary and tertiary bile acids, with a subgroup also showing lower bacterial diversity and lower abundance of microbes that can deconjugate and transform bile acids. The implication is that the bile acid mix in your stool is partly a microbiome readout.

This is why stool UDCA is most useful when interpreted as part of a broader bile acid panel. The ratio of secondary to primary bile acids, the share that UDCA occupies in that pool, and the absolute amounts together paint a more meaningful picture than UDCA alone.

Bile Acids and Other Body Systems

Bile acids reach far beyond the gut. In a large Finnish study of 10,194 men followed for a median of about 200 months (roughly 16.7 years), people with higher circulating UDCA (third quartile compared with the lowest quartile) had about 68% higher risk of ischemic stroke (adjusted hazard ratio 1.68, 95% CI 1.26 to 2.20) after adjusting for traditional cardiovascular risk factors. That study measured plasma UDCA, not stool UDCA, so it speaks to the broader biology of UDCA as a circulating metabolite rather than to your specific test.

The takeaway is that bile acid biology touches more than digestion. Whether your stool UDCA tracks with these systemic effects has not been directly established, so this is context, not a prediction about your own risk.

Tracking Your Trend

A single stool bile acid reading is a snapshot. Bile acid output varies with what you ate over the previous days, how quickly your gut moves, and the state of your microbiome at the moment of collection. One number out of pattern is rarely a verdict. A consistent shift across two or three samples taken months apart is much more informative.

A reasonable cadence is to get a baseline, retest in 3 to 6 months if you are making meaningful changes to your diet, microbiome support, or bile acid related medications, and then at least annually to keep an eye on your trajectory. Because this is a newer measurement without standardized cutpoints, building your own personal reference is exactly how you get the most out of it.

When Results Can Be Misleading

Several things can shift a single stool UDCA reading without telling you anything meaningful about your underlying biology.

• Recent oral UDCA use: if you are taking ursodiol as a medication, fecal UDCA will be markedly higher and the result no longer reflects your native bile acid metabolism.
• Recent dietary fat intake: a high-fat meal in the days before collection increases overall bile acid output and can shift the proportions in stool.
• Transit time and stool consistency: very rapid or very slow transit changes how much bile acid is absorbed before reaching your stool, distorting the measured concentration.
• Recent antibiotic use: antibiotics taken in the weeks before sampling can flatten the microbial communities that convert bile acids, temporarily changing the mix you produce.

What to Do With an Out-of-Pattern Result

If your stool UDCA pattern is unusual and persists on a repeat test, the next move is not to fixate on UDCA alone. Look at the rest of the bile acid panel, particularly the balance between primary and secondary bile acids and the levels of others like deoxycholic acid and lithocholic acid. Pair that with markers of gut inflammation such as calprotectin, with liver enzymes like ALT (alanine aminotransferase), AST (aspartate aminotransferase), ALP (alkaline phosphatase), and GGT (gamma-glutamyl transferase), and with a microbiome assessment if one is available.

If your liver enzymes are abnormal alongside an unusual bile acid pattern, a hepatologist is the right next step. If your bile acid pattern looks dysbiotic and you have gastrointestinal symptoms, a gastroenterologist focused on the microbiome can help interpret the combined picture. The point of this test is not to drive a single decision in isolation but to add a layer of resolution to a workup that already includes more established markers.